Share ownership Veeva Systems Inc.

VEEV

US9224751084

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:59:17 2026-01-23 EST			5-day change	1st Jan Change
221.78 ^USD	-1.55%		+0.11%	-0.35%

01-13	Veeva Systems Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 01:30 PM
01-08	Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership	MT

Share class: Veeva Systems Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	162,350,353	147,462,107 ( 90.83 %)	0	90.83 %

Major shareholders: Veeva Systems Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.386 %	15,429,231	9.386 %	3 444 M $
Peter Gassner 7.464 %	12,269,333	7.464 %	2 739 M $
BlackRock Advisors LLC 5.029 %	8,266,665	5.029 %	1 845 M $
Fidelity Management & Research Co. LLC 4.007 %	6,587,308	4.007 %	1 470 M $
AllianceBernstein LP 3.615 %	5,941,631	3.615 %	1 326 M $
T. Rowe Price Investment Management, Inc. 2.375 %	3,904,655	2.375 %	872 M $
Principal Global Investors LLC 2.34 %	3,846,877	2.34 %	859 M $
STATE STREET CORPORATION 2.131 %	3,503,730	2.131 %	782 M $
JPMorgan Investment Management, Inc. 2.116 %	3,478,818	2.116 %	777 M $
Geode Capital Management LLC 1.916 %	3,149,599	1.916 %	703 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	73.92%
Individuals	8.2%
Other	7.63%
State Street Corp.	2.13%
Swedbank AB	0.66%
ABN AMRO Bank NV	0.51%
Schweizerische Nationalbank	0.27%
SEI Investments Co.	0.22%
Sumitomo Mitsui Trust Group, Inc.	0.22%
Skandinaviska Enskilda Banken AB	0.18%
Danske Bank A/S	0.11%
Hancock Whitney Corp.	0.05%
Manulife Financial Corp.	0.05%
Peapack-Gladstone Financial Corp.	0.04%
Governments	0.04%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Hikari Tsushin, Inc.	0.01%
Banque Cantonale Vaudoise	0.01%
Univest Financial Corp.	0.01%
The Bank of Nova Scotia	0.01%
Unknown	5.7%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	67.13%
Individuals	8.2%
United Kingdom	7.43%
Canada	1.74%
France	1.56%
Sweden	1.52%
Australia	1.38%
Netherlands	1.15%
Norway	0.9%
Switzerland	0.59%
Denmark	0.55%
Japan	0.49%
Luxembourg	0.26%
Germany	0.26%
South Korea	0.25%
Ireland	0.16%
Hong Kong	0.12%
Liechtenstein	0.11%
Italy	0.08%
Singapore	0.07%
Belgium	0.06%
Spain	0.06%
Finland	0.06%
Austria	0.04%
Slovenia	0.03%
Israel	0.02%
Mexico	0.02%
Puerto Rico	0.02%
Taiwan	0.02%
South Africa	0.01%

Based on 1000 largest holdings

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Employees

7,291

Sector

Advanced Medical Equipment & Technology

Calendar

03-03 - Q4 2026 Earnings Release (Projected)

More about the company